Uterine fibroids are the most common type of tumor of the uterus. The main symptoms are excessive menstruation, pelvic masses, and secondary anemia. Diagnosis is relatively easy and can usually be confirmed by ultrasound or MRI. The traditional treatment of uterine fibroids is open surgery to remove the uterus or excise the fibroids, which is very traumatic and not easy for the patient to accept psychologically after the removal of the uterus. In recent decades, scholars at home and abroad have adopted interventional therapy to treat fibroids, which is effective in solving excessive menstrual bleeding and achieving the purpose of shrinking the tumor, so that patients can retain the uterus and their lives are not affected. Interventional treatment of uterine fibroids means that under the guidance of DSA, a catheter is inserted into the uterine artery through the femoral artery under the guidance of a guidewire, and drug infusion and embolization are performed to occlude the blood vessels of the fibroids, resulting in the de-vascularization of the fibroids and ischemia and hypoxia, which leads to necrosis of the fibroid cells, shrinkage of the tumor, reduction of menstrual flow, and relief of a series of clinical symptoms. Interventional treatment is suitable for most patients with fibroids, especially those who require preservation of the uterus and fertility, those for whom other treatments are ineffective or recurrent, and those who are weak and have other medical conditions that cannot tolerate surgery. The procedure is minimally invasive, requiring only a small wound of about 0.5 cm in the groin, and the dressing is removed 24 hours after the intervention and the patient is free to get out of bed.